web analytics
Family of compounds with differing dose strengths gives opportunity for formulation development | Velesco Pharma

Drug Formulation Challenge 1

Formulation Development using Challenging Vehicles

 

Our client required a common drug formulation for a family of four compounds that employed a clear, water-based vehicle to increase topical bioavailability.

  

Velesco solution

  • Within two days, Velesco developed a common drug formulation applicable to all four compounds to be dosed at three strengths each.
  • All four compound formulations demonstrated significant improvement versus control.
  • Timely delivery of the drug formulation allowed the client to meet their tight timelines for an animal clinical study.

Back to drug formulation development case studies

News and Events

 

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Gerry Cox, Founder and Chief Operating Officer at Velesco Pharmaceutical Services.

 

 

New Velesco Pharma clinical manufacturing facility begins operations. Read the press release here.

Lisa Crandall, MS, and Peter Angus, PhD, spoke with Pharmaceutical Technology about the best practices in stability testing.  Read the interview here.

 

Velesco has expanded our analytical facilities in a new Wixom, Michigan location with the help of the Bank of Ann Arbor Technology Industry Group. Read the press release here.

  

CEO Dave Barnes has been published in a new Pharmoutsourcing article on Clinical Trial Materials and Manufacturing

  

1 new job postings! Careers 

  

Velesco's work published 

  Formulation Development & Manufacturing:

Using a Single Provider Reduces Costs & Risk

Read it here.

  

Follow Velesco: 

 LinkedIn IN Icon 25px Google+ Follow VelescoPharma on Twitter  FB FindUsOnFacebook 100

 

734-274-9877